JWJingying Wu

Jingying Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jingying Wu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Liyun Zhang

    Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, China

    2 shared publications
  • Chongjuan Yin

    Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital Taiyuan China

    1 shared publication
  • Hong Zhao

    Rheumatology and Immunology Department, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, Shanxi, China

    1 shared publication
  • James Cheng-Chung Wei

    Department of Allergy, Immunology & Rheumatology Chung Shan Medical University Hospital Taichung Taiwan

    1 shared publication
  • Jiannan Han

    Third Hospital of Shanxi Medical University Shanxi Bethune Hospital Shanxi Academy of Medical Sciences Tongji Shanxi Hospital Taiyuan 030032 China

    1 shared publication
  • Jie Kang

    Third Hospital of Shanxi Medical University Shanxi Bethune Hospital Shanxi Academy of Medical Sciences Tongji Shanxi Hospital Taiyuan 030032 China

    1 shared publication

Latest Publications

  • Labyrinth of Rheumatic Disease: Finding the Optimal Path to Managing Cardiovascular Risk

    by Jingying Wu, Qianyu Guo, Chongjuan Yin, James Cheng‐Chung Wei, Li‐Yun Zhang

  • Open Access

    Investigating the Impact of Gut Microbiota and Immune Cells on Ankylosing Spondylitis From a Genetic Perspective: A Mendelian Randomization and Mediation Study

    by Jiannan Han, Jingying Wu, Hong Zhao, Yangyu Xu, Yuxiang Gao, Jie Kang, Junkang Zhao, Liyun Zhang

    Background: Previous studies have separately reported causal relationships between gut microbiota and ankylosing spondylitis (AS), as well as between immune cells and AS. However, the potential causal relationships between gut microbiota/immune cells and AS have not been explored. In this study, we elucidated the role of gut microbiota in the progression of AS through the regulation of immune cells. Methods: Inverse‐variance weighted (IVW) was used as the primary analysis method, supplemented by MR‒Egger, simple mode, weighted median, and weighted mode methods to determine the causal relationships between gut microbiota and AS. Additionally, Bayesian weighted Mendelian randomization (BWMR) was used to identify the strongest causal associations, and mediation MR analysis was performed to explore the potential mediating role of immune cells in the relationship between gut microbiota and AS. Results: MR analysis identified 13 microbial taxa significantly associated with AS, of which eight were significantly associated with an increased risk of AS. Additionally, five microbial taxa were significantly associated with a reduced risk of AS. Furthermore, 19 immunophenotypes were significantly associated with AS, of which 11 were linked to an increased risk of AS. Additionally, eight immune cells were associated with a reduced risk of AS. Mediation MR analysis revealed that two immune cells mediated the causal relationships of two gut microbiota: CX3CR1 on monocyte mediated a 7.91% increase in AS risk through the CAG‐83 sp000435555 abundance in stool pathway, and CD45 on CD33 − HLA DR − mediated a 12.04% increase in AS risk through the Clostridium S felsineum abundance in stool pathway. Multiple sensitivity analyses confirmed the robustness of our results. Conclusion: This study is the first to reveal the causal relationships among gut microbiota, immune cells, and AS. These findings provide genetic evidence supporting a potential causal role of gut microbiota in AS, suggesting that immune cells may act as mediators.